Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
25,799,127
-
Share change
-
-1,125,752
-
Total reported value
-
$322,227,437
-
Price per share
-
$12.49
-
Number of holders
-
63
-
Value change
-
-$12,715,178
-
Number of buys
-
29
-
Number of sells
-
25
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q1 2019
As of 31 Mar 2019,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,799,127 shares.
The largest 10 holders included
Alphabet Inc., WELLINGTON MANAGEMENT GROUP LLP, Svennilson Peter, BVF INC/IL, BlackRock Inc., Foresite Capital Management III, LLC, VANGUARD GROUP INC, EcoR1 Capital, LLC, STATE STREET CORP, and JANUS HENDERSON GROUP PLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.